These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 9374342

  • 21. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects.
    Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, Tikofsky RS, Stabin MG, Morgan RA, Goldsmith SJ.
    J Nucl Med; 1989 May; 30(5):599-604. PubMed ID: 2497233
    [Abstract] [Full Text] [Related]

  • 22. A brain metastasis, with no uptake of 99mTc-ECD, secondary to Hurtle cell carcinoma of the thyroid.
    Orsolon P, Bagni B, Cattaruzzi E, Englaro E, Guerra UP.
    Minerva Endocrinol; 1995 Dec; 20(4):233-6. PubMed ID: 8709920
    [Abstract] [Full Text] [Related]

  • 23. Brain PET and technetium-99m-ECD SPECT imaging in Lhermitte-Duclos disease.
    Ogasawara K, Yasuda S, Beppu T, Kobayashi M, Doi M, Kuroda K, Ogawa A.
    Neuroradiology; 2001 Nov; 43(11):993-6. PubMed ID: 11760808
    [Abstract] [Full Text] [Related]

  • 24. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction.
    Holman BL, Hellman RS, Goldsmith SJ, Mena IG, Leveille J, Gherardi PG, Moretti JL, Bischof-Delaloye A, Hill TC, Rigo PM.
    J Nucl Med; 1989 Jun; 30(6):1018-24. PubMed ID: 2661751
    [Abstract] [Full Text] [Related]

  • 25. [Metabolism of 99mTc-ethyl cysteinate dimer (99mTc-ECD) in blood--mainly in vitro].
    Inoue Y, Momose T, Amo K, Ohtake T, Watanabe T, Kosaka N, Nishikawa J, Sasaki Y.
    Kaku Igaku; 1992 Aug; 29(8):955-62. PubMed ID: 1434085
    [Abstract] [Full Text] [Related]

  • 26. [Short interval change of 99mTc-ethyl cysteinate dimer single photon emission computed tomography in Wilson's disease].
    Imai N, Nozaki H, Miyata K, Terayama Y, Ishihara N.
    No To Shinkei; 1999 Sep; 51(9):785-9. PubMed ID: 10511956
    [Abstract] [Full Text] [Related]

  • 27. [Phase I clinical study of 99mTc-ECD].
    Kubo A, Nakamura K, Tsukatani Y, Sanmiya T, Shimizu S, Yokoyama K, Hashimoto S, Torizuka K.
    Kaku Igaku; 1992 Aug; 29(8):1019-27. PubMed ID: 1434082
    [Abstract] [Full Text] [Related]

  • 28. Importance of the two ester functions for the brain retention of 99mTc-labelled ethylene dicysteine diethyl ester (99mTc-ECD).
    Vanbilloen HP, Cleynhens BJ, Verbruggen AM.
    Nucl Med Biol; 1998 Aug; 25(6):569-75. PubMed ID: 9751425
    [Abstract] [Full Text] [Related]

  • 29. OAT3-mediated extrusion of the 99mTc-ECD metabolite in the mouse brain.
    Kikuchi T, Okamura T, Wakizaka H, Okada M, Odaka K, Yui J, Tsuji AB, Fukumura T, Zhang MR.
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):585-8. PubMed ID: 24496177
    [Abstract] [Full Text] [Related]

  • 30. Formulation of a single-component kit for the preparation of technetium-99m labelled ethyl cysteinate dimer: biological and clinical evaluation.
    Afshan A, Jehangir M, Ashraf M, Waqar A, Chiotellis E.
    Eur J Nucl Med; 1994 Sep; 21(9):991-5. PubMed ID: 7995295
    [Abstract] [Full Text] [Related]

  • 31. Preliminary studies of acetylcholinesterase activity in the rat brain using N-phenylferrocenecarboxamide labelled by the technetium-99m.
    Mejri N, Said NM, Guizani S, Essouissi I, Saidi M.
    Nucl Med Biol; 2013 May; 40(4):561-6. PubMed ID: 23465564
    [Abstract] [Full Text] [Related]

  • 32. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 7th communication: in vitro metabolism.
    Yamada Y, Otsuka M, Takaiti O.
    Arzneimittelforschung; 1992 Apr; 42(4):507-12. PubMed ID: 1642674
    [Abstract] [Full Text] [Related]

  • 33. Regional differences in technetium-99m-ECD clearance on brain SPECT in healthy subjects.
    Ichise M, Golan H, Ballinger JR, Vines D, Blackman A, Moldofsky H.
    J Nucl Med; 1997 Aug; 38(8):1253-60. PubMed ID: 9255160
    [Abstract] [Full Text] [Related]

  • 34. [A case of bone metastases from carcinoma of the lung demonstrating increased uptake of 99mTc-ECD].
    Yasuda H, Oonishi I, Sui O.
    Kaku Igaku; 2000 Nov; 37(6):675-9. PubMed ID: 11193454
    [Abstract] [Full Text] [Related]

  • 35. [Interaction of dialkyl(alpha-carbomethoxy-beta,beta,beta-trifluoro- ethyl) phosphates with mammalian esterases].
    Makhaeva GF, Fetisov VI, Sokolov VB, Iankovskaia VL, Goreva TV.
    Bioorg Khim; 1987 Jan; 13(1):33-7. PubMed ID: 3566818
    [Abstract] [Full Text] [Related]

  • 36. Regional cerebral blood flow and distribution of [99mTc]ethyl cysteinate dimer in nonhuman primates.
    Orlandi C, Crane PD, Platts SH, Walovitch RC.
    Stroke; 1990 Jul; 21(7):1059-63. PubMed ID: 2368107
    [Abstract] [Full Text] [Related]

  • 37. [Properties of the nervous tissue cholinesterase and carboxylesterase in the locust, Locusta migratoria].
    Tiliabaev Z.
    Zh Evol Biokhim Fiziol; 1978 Jul; 14(4):405-7. PubMed ID: 676590
    [Abstract] [Full Text] [Related]

  • 38. Retention of Tc-99m ECD in delayed SPECT of the brain.
    Flores LG, Jinnouchi S, Nagamachi S, Ohnishi T, Futami S, Nakahara H, Shimoshinbara S, Ushinbana K, Tamura S.
    Ann Nucl Med; 1999 Feb; 13(1):1-4. PubMed ID: 10202941
    [Abstract] [Full Text] [Related]

  • 39. Technetium-99m-ECD SPECT in antiphospholipid antibody syndrome: a drastic improvement in brain perfusion by antiplatelet therapy.
    Tokumaru S, Yoshikai T, Uchino A, Matsui M, Kuroda Y, Kudo S.
    Eur Radiol; 2001 Feb; 11(12):2611-5. PubMed ID: 11734968
    [Abstract] [Full Text] [Related]

  • 40. Characterization and preliminary evaluation of ester-modified technetium-99m SNS/S mixed ligand complexes as potential brain perfusion agents.
    Tsoukalas C, Papadopoulos MS, Maina T, Pirmettis IC, Nock BA, Raptopoulou C, Terzis A, Chiotellis E.
    Nucl Med Biol; 1999 Apr; 26(3):297-304. PubMed ID: 10363801
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.